Purpose
Identification
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80325
80359
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Amphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant, Anorexogenic
2 Methamphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant
3 MDA Adam; Methylenedioxyamphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant
4 MDMA 3,4-Methylenedioxymethamphetamine; Ecstasy High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant

Test Also Known As
Molly; XTC
Specimen Type
Oral Fluid (Saliva)
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
Collect oral fluid according to manufactuer's directions. Pour-off containers are acceptable. DO NOT FREEZE.
Specimen Container
Oral Fluid collection device

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): Undetermined

The stability information provided is for the Quantisal(TM) collection device with the pad inside of the device. For other devices, follow manufacturer's recommendations.
1 Amphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant, Anorexogenic
2 Methamphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant
3 MDA Adam; Methylenedioxyamphetamine High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant
4 MDMA 3,4-Methylenedioxymethamphetamine; Ecstasy High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2.5 Stimulant

Interface Map

LOINC® Information